Delia Motavalli1, Jessica L Taylor2,3, Ellen Childs4, Pablo K Valente5, Peter Salhaney5,6, Jennifer Olson6, Dea L Biancarelli4, Alberto Edeza5,6, Joel J Earlywine4, Brandon D L Marshall7, Mari-Lynn Drainoni4,8,9,10, Matthew J Mimiaga5,6,7,11,12, Katie B Biello5,6,7,11, Angela R Bazzi13. 1. Boston University School of Medicine, Boston, MA, USA. 2. Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. 3. Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA. 4. Department of Health Law, Policy & Management, Boston University School of Public Health, Boston, MA, USA. 5. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA. 6. Center for Health Equity Research, Brown University, Providence, RI, USA. 7. Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA. 8. Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. 9. Evans Center for Implementation and Improvement Sciences, Boston University School of Medicine, Boston, MA, USA. 10. Center for Healthcare Organization and Implementation Research, ENRM VA Hospital, Bedford, MA, USA. 11. The Fenway Institute, Fenway Health, Boston, MA, USA. 12. Department of Psychiatry and Human Behavior, Brown University Alpert Medical School, Providence, RI, USA. 13. Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, 02118, USA. abazzi@bu.edu.
Abstract
BACKGROUND: The estimated 2.2 million people who inject drugs (PWID) in the USA experience significant gaps in preventive healthcare and a high burden of infectious, psychiatric, and other chronic diseases. Many PWID rely on emergency medical services, which are costly and not designed to deliver preventive services, manage chronic conditions, or address social needs. OBJECTIVE: The objective of this study was to explore barriers and facilitators to primary care utilization from the perspectives of PWID in New England, a region highly affected by the overdose crisis. DESIGN: Participants completed semi-structured qualitative interviews exploring substance use and healthcare utilization patterns. PARTICIPANTS: We recruited 78 PWID through community-based organizations (e.g., syringe service programs) in 16 urban and non-urban communities throughout Massachusetts and Rhode Island. APPROACH: Thematic analysis identified barriers and facilitators to primary care utilization at the individual, interpersonal, and systemic levels. KEY RESULTS: Among 78 PWID, 48 described recent primary care experiences; 33 had positive experiences and 15 described negative experiences involving discrimination or mistrust. Individual-level barriers to primary care utilization included perceived lack of need and competing priorities (e.g., avoiding opioid withdrawal, securing shelter beds). Interpersonal-level barriers included stigma and perceived low quality of care for PWID. Systemic-level barriers included difficulty navigating healthcare systems, inadequate transportation, long wait times, and frequent provider turnover. Participants with positive primary care experiences explained how appointment reminders, flexible hours, addiction medicine-trained providers, case management services, and transportation support facilitated primary care utilization and satisfaction. CONCLUSIONS: Findings regarding the multilevel barriers and facilitators to accessing primary care among PWID identify potential targets for programmatic interventions to improve primary care utilization in this population. Based on these findings, we make recommendations for improving the engagement of PWID in primary care as a means to advance individual and public health outcomes.
BACKGROUND: The estimated 2.2 million people who inject drugs (PWID) in the USA experience significant gaps in preventive healthcare and a high burden of infectious, psychiatric, and other chronic diseases. Many PWID rely on emergency medical services, which are costly and not designed to deliver preventive services, manage chronic conditions, or address social needs. OBJECTIVE: The objective of this study was to explore barriers and facilitators to primary care utilization from the perspectives of PWID in New England, a region highly affected by the overdose crisis. DESIGN: Participants completed semi-structured qualitative interviews exploring substance use and healthcare utilization patterns. PARTICIPANTS: We recruited 78 PWID through community-based organizations (e.g., syringe service programs) in 16 urban and non-urban communities throughout Massachusetts and Rhode Island. APPROACH: Thematic analysis identified barriers and facilitators to primary care utilization at the individual, interpersonal, and systemic levels. KEY RESULTS: Among 78 PWID, 48 described recent primary care experiences; 33 had positive experiences and 15 described negative experiences involving discrimination or mistrust. Individual-level barriers to primary care utilization included perceived lack of need and competing priorities (e.g., avoiding opioid withdrawal, securing shelter beds). Interpersonal-level barriers included stigma and perceived low quality of care for PWID. Systemic-level barriers included difficulty navigating healthcare systems, inadequate transportation, long wait times, and frequent provider turnover. Participants with positive primary care experiences explained how appointment reminders, flexible hours, addiction medicine-trained providers, case management services, and transportation support facilitated primary care utilization and satisfaction. CONCLUSIONS: Findings regarding the multilevel barriers and facilitators to accessing primary care among PWID identify potential targets for programmatic interventions to improve primary care utilization in this population. Based on these findings, we make recommendations for improving the engagement of PWID in primary care as a means to advance individual and public health outcomes.
Entities:
Keywords:
patient acceptance of health care; preventive health services; primary health care; quality of health care; social stigma; substance-related disorders
Authors: Sarah H Heil; Hendree E Jones; Amelia Arria; Karol Kaltenbach; Mara Coyle; Gabriele Fischer; Susan Stine; Peter Selby; Peter R Martin Journal: J Subst Abuse Treat Date: 2010-10-30
Authors: Bradley M Mathers; Louisa Degenhardt; Chiara Bucello; James Lemon; Lucas Wiessing; Mathew Hickman Journal: Bull World Health Organ Date: 2013-02-01 Impact factor: 9.408
Authors: Marija Zeremski; Jon E Zibbell; Anthony D Martinez; Steven Kritz; Bryce D Smith; Andrew H Talal Journal: World J Gastroenterol Date: 2013-11-28 Impact factor: 5.742
Authors: Marisa Felsher; Karin E Tobin; Mark Sulkowski; Carl Latkin; Oluwaseun Falade-Nwulia Journal: Drug Alcohol Depend Date: 2021-10-29 Impact factor: 4.492
Authors: Angela R Bazzi; Chad J Valasek; Samantha A Streuli; Carlos F Vera; Alicia Harvey-Vera; Morgan M Philbin; Katie B Biello; Alexis M Roth; Steffanie A Strathdee; Heather A Pines Journal: AIDS Patient Care STDS Date: 2022-06-21 Impact factor: 5.944
Authors: Carl G Streed; Jake R Morgan; Mam Jarra Gai; Marc R Larochelle; Michael K Paasche-Orlow; Jessica L Taylor Journal: JAMA Netw Open Date: 2022-07-01
Authors: Shannon N Ogden; Miriam Th Harris; Ellen Childs; Pablo K Valente; Alberto Edeza; Alexandra B Collins; Mari-Lynn Drainoni; Matthew J Mimiaga; Katie B Biello; Angela R Bazzi Journal: Int J Drug Policy Date: 2021-05-10
Authors: Katie B Biello; Matthew J Mimiaga; Pablo K Valente; Nimish Saxena; Angela R Bazzi Journal: Curr HIV/AIDS Rep Date: 2021-04-27 Impact factor: 5.495
Authors: Kathryn Hawk; Ryan McCormack; E Jennifer Edelman; Edouard Coupet; Nicolle Toledo; Phoebe Gauthier; John Rotrosen; Marek Chawarski; Shara Martel; Patricia Owens; Michael V Pantalon; Patrick O'Connor; Lauren K Whiteside; Ethan Cowan; Lynne D Richardson; Michael S Lyons; Richard Rothman; Lisa Marsch; David A Fiellin; Gail D'Onofrio Journal: JAMA Netw Open Date: 2022-01-04
Authors: Kristina T Phillips; Catherine Stewart; Bradley J Anderson; Jane M Liebschutz; Debra S Herman; Michael D Stein Journal: Drug Alcohol Depend Date: 2021-02-27 Impact factor: 4.492
Authors: Deborah S Hasin; David S Fink; Mark Olfson; Andrew J Saxon; Carol Malte; Katherine M Keyes; Jaimie L Gradus; Magdalena Cerdá; Charles C Maynard; Salomeh Keyhani; Silvia S Martins; Ofir Livne; Zachary L Mannes; Scott E Sherman; Melanie M Wall Journal: Drug Alcohol Depend Date: 2022-03-03 Impact factor: 4.852